Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

Philips Collaborates On Program For Medication Adherence

By Zacks Investment ResearchStock MarketsMar 11, 2018 11:00PM ET
www.investing.com/analysis/philips-collaborates-on-program-for-medication-adherence-200297403
Philips Collaborates On Program For Medication Adherence
By Zacks Investment Research   |  Mar 11, 2018 11:00PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
CSCO
+0.45%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
INTU
+2.24%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
PHG
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SMCAY
-0.93%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Koninklijke Philips N.V. (NYSE:PHG) announced its participation in two programs which will attempt to improve medication adherence rates among at-risk, high-cost patient populations.

Leveraging the Philips Medication Adherence Solution (PMAS), Lynn Community Health Center of Lynn, Mass will work with Partners Connected Health of Partners HealthCare to implement a Philips connected in-home medication dispensing solution to help improve treatment plan compliance among patients with mental illness. Triad HealthCare Network of Greensboro, N.C. will also incorporate Philips medication dispensing device in a program designed to improve patient medication adherence among chronic disease patients within the Medicare Advantage population.

PMAS aims to achieve the quadruple aim of healthcare — better clinical outcome, lower cost, improved patient and staff satisfaction through integrated solutions to help provide high quality care and manage cost and utilization while improving outcomes and revenues.

Medication non-adherence costs the U.S. health system more than $310 billion every year and results in hundreds of thousands of preventable deaths annually. Through this program, the company aims to discover an effective method to give complex patients with a history of non-adherence, the ability to stay on track easily. This is likely to reduce unnecessary emergency transports and hospitalizations while effectively manage the cost of care.

Health systems work to better manage high-risk, high-cost patients to deliver value-based care successfully. So, it is important for the company to have access to the right data with actionable insights. PMAS offers care providers data-driven insights to help optimize medication management and increase patient engagement.

Thus, Philips’ data aggregation platforms provide continuous and seamless availability of data and their interpretation to help improve patient outcomes and financial results. By partnering with spencer Health Solutions, Philips offers a connected ecosystem, a monitored in-home dispensing device, pre-packaged, unit-dose medications from mail order and specialty pharmacies, a clinician portal and a caregiver app.

Philips’ Healthcare segment has been showing impressive momentum in recent quarters and the company believes that increased spending on healthcare and fitness will continue to act as a meaningful growth driver.



Philips shares have outperformed the industry in the last three months, having gained 1.8% compared with a growth of 0.9% for the latter. Philips has a Zacks Rank #3 (Hold). Better-ranked stocks in the industry include SMC Corporation (OTC:SMCAY) , Cisco Systems (NASDAQ:CSCO), Inc. CSCO and Intuit Inc (NASDAQ:INTU). INTU, each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

SMC Corporation has an expected long-term earnings growth rate of 12.9%.

Cisco Systems exceeded estimates thrice in the trailing four quarters with an average beat of 3%.

Intuit surpassed estimates in each of the four trailing quarters, the average being 37.2%.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>



Koninklijke Philips N.V. (PHG): Free Stock Analysis Report

Control4 Corporation (CTRL): Free Stock Analysis Report

Smc Corporation (SMCAY): Free Stock Analysis Report

DAIKIN INDS LTD (DKILY): Free Stock Analysis Report

Original post

Zacks Investment Research

Philips Collaborates On Program For Medication Adherence
 

Related Articles

Philips Collaborates On Program For Medication Adherence

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email